Scientists meet to plan ongoing work in support of livestock vaccines and diagnostics. Scientists have met to launch the second phase of a collaboration focused on livestock antibody research, in support of the development of vaccines and diagnostics for animal diseases. A renewed five-year funding award will support experts from The Pirbright Institute and Roslin Institute to continue the work of the Livestock Antibody Hub, which seeks to understand antibody responses to infection in cattle, pig and poultry. The hub, established in 2019, aims to expand knowledge of protective immunity in species that can also be used as models for a range of human infectious diseases. The latest investment from the Gates Foundation will enable the Hub to continue providing researchers and vaccine developers with the specialist expertise, tools and technologies needed to accelerate innovation and improve livestock health worldwide. Multiple benefits By enabling informed vaccine design and advancing new approaches to disease prevention and treatment, the Hub’s researchers aim to improve animal health and welfare, strengthen food security, and support resilient farming systems. The programme will also seek to benefit smallholder farmers who depend on healthy livestock for their livelihoods. Professor John Hammond, Director of the Roslin Institute, opened the meeting at the Roslin Institute by introducing the vision and objectives for the next phase, Hub 2.0, and reflected on the achievements of the programme to date. Nick Juleff, Deputy Director at the Gates Foundation, outlined the Foundation's current priorities and strategic direction. Scientific presentations from Hub partners showcased the breadth of research being supported through the programme, from structural vaccinology to improving mucosal vaccine responses, before discussions turned to project delivery, collaboration and priorities for the next phase. The Hub will continue to act as a source of trusted expertise and capabilities for the study of antibodies in a range of livestock species. As such, existing and new projects will continue to be supported across the UK and around the world, aiming to develop and improve vaccines and diagnostics to a range of critical diseases. Professor John Hammond Director, Roslin Institute The Roslin Institute receives strategic investment funding from the Biotechnology and Biological Sciences Research Council and it is part of the University of Edinburgh’s Royal (Dick) School of Veterinary Studies. Related links The Pirbright Institute Tags News Roslin This article was published on Friday 14 August 2026
